Gut · 1998 · 79 citations · 18 references
AgricultureFood ScienceNutritionFood AnalysisFood ChemistryMucosal ImmunologyAntibody CharacterizationAntigen Detection AssaysCeliac DiseaseEnzyme-linked Immunosorbent AssayImmunoassay AnalysisProtein AnalysisAssayCeliac Disease SerologyCeliac SerologyDouble Antibody Sandwich AssaysMonoclonal Antibody RecognitionSandwich Enzyme-linked Immunosorbent AssaySensitivitySmall Intestinal Pathology
BACKGROUND: Future European Community regulations will require a sensitive and specific assay for measurement of coeliac toxic gluten proteins in foods marketed as gluten-free. To avoid spurious cross reactions with non-toxic proteins, specific antibodies and target antigens are required. A synthetic 19 amino acid peptide of A gliadin has been shown to cause deterioration in the morphology of small intestinal biopsy specimens of coeliac patients in remission. AIMS: To develop an assay for detection of gluten in foods, based on measurement of a known toxic peptide. METHODS: A monoclonal antibody raised against the toxic A gliadin peptide, with a polyclonal anti-unfractionated gliadin capture antibody, was used to develop a double sandwich enzyme linked immunosorbent assay (ELISA) for the measurement of gluten in foods. RESULTS: Standard curves for gliadin and for rye, barley, and oat prolamins were produced. The sensitivity of the assay was 4 ng/ml of gliadin, 500 ng/ml for rye prolamins, and 1000 ng/ml for oat and barley prolamins. The assay could detect gluten in cooked foods, although at reduced sensitivity. Prolamins from coeliac non-toxic rice, maize, millet, and sorghum did not cross react in the assay. A variety of commercially available gluten-free foods were analysed; small quantities of gluten were detected in some products. CONCLUSION: The assay may form the basis of a sensitive method for measurement of gluten in foods for consumption by patients with coeliac disease.
18
Malignancy in coeliac disease--effect of a gluten free diet.
Geoffrey Holmes, P Prior, M. R. Lane et al. · Gut · 1989 · 979 citations · Full text
Wheat peptide challenge in coeliac disease
Richard Sturgess, Phillip Day, H J Ellis et al. · The Lancet · 1994 · 259 citations
Clinical Testing of Gliadin Fractions in Coeliac Patients
Paul J. Ciclitira, David J. Evans, N. L. K. Fagg et al. · Clinical Science · 1984 · 165 citations
Pharmacy, Biochemistry, Toxicology +13